Compare STTK & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STTK | ATLO |
|---|---|---|
| Founded | 2016 | 1903 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.9M | 239.2M |
| IPO Year | 2020 | 2001 |
| Metric | STTK | ATLO |
|---|---|---|
| Price | $6.37 | $27.63 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $7.60 | N/A |
| AVG Volume (30 Days) | ★ 657.3K | 37.3K |
| Earning Date | 03-05-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 2.90% |
| EPS Growth | ★ 53.02 | 8.03 |
| EPS | N/A | ★ 0.38 |
| Revenue | ★ $1,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $72.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.69 | $16.09 |
| 52 Week High | $6.31 | $28.35 |
| Indicator | STTK | ATLO |
|---|---|---|
| Relative Strength Index (RSI) | 73.85 | 58.69 |
| Support Level | $1.85 | $25.95 |
| Resistance Level | N/A | $28.07 |
| Average True Range (ATR) | 0.40 | 0.71 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 79.43 | 82.20 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Ames National Corporation is a bank holding company based in the United States. Through its subsidiaries, it provides a range of banking and other financial products and services to customers in Iowa, mainly in Boone, Clarke, Hancock, Marshall, Polk, Story, Taylor, and Union in central, north-central, and south-central Iowa. The Group offers several financial products and services, including checking and savings accounts, time deposits, commercial, construction, and agricultural loans, personal loans, lines of credit, cash management services, merchant credit card processing, safe deposit boxes, and ATM services, among others. It caters to the banking needs of a diverse range of customers, including individuals, businesses, professionals, and enterprises.